𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340

✍ Scribed by Beverley J. Randle; M.A. Epstein

Book ID
119114168
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
479 KB
Volume
9
Category
Article
ISSN
0166-0934

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of an enzyme-linked immunoso
Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the epstein-barr virus
✍ Wu-Ching Uen; Janos Luka; Gary R. Pearson πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 506 KB

A 3-step enzyme-linked immunosorbent assay (ELISA) was developed for detecting IgA antibodies to purified Epstein-Barr virus (EBV) polypeptides. The 3-step procedure included the use of a mouse anti-human IgA monoclonal antibody (MAb) to amplify the IgA reaction. The 2 major EBV proteins used in thi

Sensitive enzyme-linked immunosorbent as
Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen
✍ Edward H. Wasmuth; William J. Miller πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 510 KB

## Abstract The development of an ELISA of increased sensitivity has permitted a more critical evaluation of human humoral immune responses to the live attenuated varicella (Oka/Merck) vaccine. For use as a solid‐phase antigen, the glycoprotein (gp) antigens are prepared by lectin‐affinity chromato

Enzyme-Linked immunosorbent assay (ELISA
Enzyme-Linked immunosorbent assay (ELISA) for IgA and IgG antibodies to epstein-barr-virus ribonucleotide reductase in patients with nasopharyngeal carcinoma
✍ A. Fones-Tan; S. H. Chan; S. Y. Tsao; L. H. Gan; W. H. Tan; B. Li; P. W. Khong; πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 506 KB

661 bp coding for the carboxyl end of the large sub-unit of EBV ribonucleotide reductase was cloned into the pMal plasmid vector. Purified recombinant protein was tested in IgG and IgA ELISAs. For the IgG assay, 81 out of 100 NPC patients tested positive, whereas for the IgA assay, 60 tested positiv